Physician Dispensing: An Overview of Maryland Law and Regulation

Physician Dispensing: An Overview of Maryland Law and Regulation

This module was Board-approved and DHMH Secretary-approved to meet the CME requirements for dispensing permits.

This module will address the laws relating to a physician’s legal right to dispense prescription drugs, which the physician prescribes to his or her patients.  The requirements and process for obtaining permission from the appropriate state board will be covered.  Through learning exercises and online course presentations, the module will emphasize requirements for labeling, filing, inspections and other laws that previously had been primarily directed toward pharmacies.  Situations where a prescriber can dispense a prescription drug without the necessity of obtaining special permission from his or her state board will be detailed.   

CE: 1.0 AMA PRA Category 1 Credit™, 1.0 ACPE Contact Hours
Universal Activity Number (UAN): 0025-0000-16-086-H03-P
Expiration Date: 06/21/2019
Course Number: KE-CN#MD001
Target Audience: Physicians, Pharmacists, Dentists
Instructor: Frank Palumbo, JD, PhD, Professor and Executive Director of the Center on Drugs and Public Policy, University of Maryland School of Pharmacy

Other courses in this series include:

Learning Objectives (Physicians):
At the end of this course, the physician participant should be able to:

  1. Know the basic content of the physician dispensing statute and identify where to find related regulations online;
  2. Understand the conditions under which physicians can legally dispense prescription drugs to their parents; and
  3. Know the specific requirements for physicians to dispense starter doses, samples, and in certain medical facilities or clinics.

Learning Objectives (Pharmacists):
At the end of this course, the pharmacist participant should be able to:

  1. Identify the location of publicly accessible physician dispensing statute and up-to-date dispensing regulations;
  2. Differentiate between the situations where physicians can and cannot dispense drugs…..under Maryland law; and
  3. Determine how starter doses, samples, and certain specific medical facilities and clinics are treated under the Maryland Law

Your Instructor

Frank Palumbo, JD, PhD
Professor and Executive Director of the Center on Drugs and Public Policy
University of Maryland School of Pharmacy

View Bio

Disclosures
Planners: The planners for this activity have reported no relevant relationships to disclose.
Presenters:
Physician Dispensing: An Overview of Maryland Law and Regulation
Frank Palumbo, JD, PhD, has reported no relevant relationships to disclose.

Technology Requirements

 To access the course materials, you must use a computer with an internet connection and an online browser that supports the Adobe® Flash® Player version 10.  Mozilla® Firefox, Windows Internet Explorer 9 or higher, or Apple® Safari® for desktop are acceptable browsers.   

Successful Completion: Learners must complete all practice based activity components including the audiovisual presentations, post-test, and Activity Evaluation.  Participants must receive a score of at least 70% on the post-test in order to receive credit.  The post-test may be taken up to three (3) times. A link to the Activity Evaluation will be available on the confirmation once a learner has successfully completed the post-test. In order to receive CE credits, learners must complete the Activity Evaluation.  Statements of CE Credit will be available electronically via CPE Monitor within sixty (60) days of completion of the activity.

Conflict of Interest Disclosure: In accordance with the University of Maryland School of Pharmacy Policy on Conflicts of Interest, faculty certify that they had no potential conflicts of interest while developing the materials for this program.

Disclosure and Transparency in CME/CPD:
It is MedChi’s policy to ensure the independence, transparency, balance, objectivity, scientific rigor and integrity, as well as validation of content for all CME/CPD activities we accredit. To that end, faculty must disclose to the participants any relationships with companies identified as meeting the ACCME definition of a commercial interest. In the process of the disclosure process, all faculty and planners have disclosed the presences or absence of such relationships to MedChi. MedChi has identified, evaluated and where appropriate, attempted to resolve any potential conflicts of interest. This is done through the use of content validation, the use of evidence-based data, and multi-disciplinary peer review. The information provided as disclosure to the learner, is to inform the learner and aide in judgment, not to imply that disclosed relationships will have a negative effect on a presentation.

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of  MedChi, The Maryland State Medical Society, and The University of Maryland School of Pharmacy. MedChi is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statements:
Physician Dispensing: An Overview of Maryland Law and Regulation
MedChi designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dispensing:
This module was Board-approved and DHMH Secretary-approved to meet the CME requirements for dispensing permits.

CME Credit: In order to receive CME credit for participation in these modules the learner is required to complete a post-test and achieve a score of 70% or higher for each module

Use of Trade Names:  The trade names of the drugs and delivery systems in this module are for the purpose of product identification only. The developers of this activity do not intend to imply endorsement for any commercial products discussed.

Resource Disclosure: Resources are provided for the educational benefit of our learners.  These materials are not for distribution.

Privacy and Confidentiality: The Center for Innovative Pharmacy Solutions (CIPS) is committed to protect the privacy of our learners; CIPS complies with federal regulations regarding privacy and confidentiality.  Email addresses may be used periodically to update learners on course offerings and new learning resources.  Certain personal information will be provided to the professional certifying entity in order to issue Certificates of Credit.  No personal information will be sold to third parties.  Your Activity Evaluation responses will be analyzed in aggregate. 

Copyright: All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission from CIPS.  All rights reserved. 

The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Refund Policy
  • A refund, less a $50 administration fee, will be made if cancellations are requested within 15 days. Other restrictions may apply.
  • Refund requests must be submitted in writing to cips@rx.umaryland.edu.
  • Refunds are not available in the following circumstances:
    • A learner has logged into a course or series;
    • Has launched course materials;
    • Course materials have been shipped; or
    • Request is made after 15 days of the ordering date.
  • Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questions page.  Can't find what you are looking for?  Contact Customer Service at cips@rx.umaryland.edu or 410-706-3381.